Dominic Oliver

Dominic Oliver

Early Psychosis: Interventions and Clinical-detection (EPIC) lab, King's College London

Affiliated withKing's College London

Research Area

Biography

Dominic is a PhD student at the Institute of Psychiatry, King’s College London, under the supervision of Dr Paolo Fusar-Poli and Professor Philip McGuire. Dominic’s research interests involve finding better ways to identify people at risk for psychosis and the interplay between psychosis risk and cannabis. His current studies investigate: a) environmental risk factors for psychosis and, b) different ratios of CBD:THC to find the optimum ratio that reduces the harmful effects of cannabis

Before joining the Institute of Psychiatry, Psychology and Neuroscience, Dominic completed an MSc in Cognitive Neuroscience at University College London before working as a research assistant in the Social Neuroscience lab at the Institute of Cognitive Neuroscience, University College London.

JoVE Journal Publications

ArticleTotal : 1
Year
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Publication title

Cited by 34

2020

Other Publications

Article
Year
Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.

Schizophrenia bulletin| PubMed ID: 28521060

2018
2018
What causes psychosis? An umbrella review of risk and protective factors.

World psychiatry : official journal of the World Psychiatric Association (WPA)| PubMed ID: 29352556

2018
2018
Meta-analytical prognostic accuracy of the Comprehensive Assessment of at Risk Mental States (CAARMS): The need for refined prediction.

European psychiatry : the journal of the Association of European Psychiatrists| PubMed ID: 29413807

2018
Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventions.

European psychiatry : the journal of the Association of European Psychiatrists| PubMed ID: 29787962

2018
2019
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology| PubMed ID: 30626906

2019
Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services.

European psychiatry : the journal of the Association of European Psychiatrists| PubMed ID: 30658277

2019
Neurochemical effects of oxytocin in people at clinical high risk for psychosis.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology| PubMed ID: 30928180

2019
2019
2019
2019
How experimental cannabinoid studies will inform the standardized THC unit.

Addiction (Abingdon, England)| PubMed ID: 32022348

2020
2020
2020
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology| PubMed ID: 32268347

2020
2020